ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 77 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2013. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $54,000 | -3.6% | 10,045 | +0.4% | 0.03% | -46.4% |
Q3 2016 | $56,000 | -62.4% | 10,000 | -50.1% | 0.06% | -72.5% |
Q1 2016 | $149,000 | +79.5% | 20,045 | +99.6% | 0.20% | +300.0% |
Q4 2015 | $83,000 | -75.7% | 10,045 | -64.6% | 0.05% | -75.9% |
Q2 2015 | $341,000 | -62.8% | 28,408 | -66.6% | 0.21% | -65.4% |
Q1 2015 | $917,000 | +201.6% | 85,090 | +41.8% | 0.61% | +273.2% |
Q4 2014 | $304,000 | +1069.2% | 60,000 | +500.0% | 0.16% | +811.1% |
Q3 2014 | $26,000 | -35.0% | 10,000 | 0.0% | 0.02% | -28.0% |
Q2 2014 | $40,000 | -65.2% | 10,000 | -60.0% | 0.02% | -59.7% |
Q1 2014 | $115,000 | +5.5% | 25,000 | 0.0% | 0.06% | +17.0% |
Q4 2013 | $109,000 | -44.9% | 25,000 | -50.0% | 0.05% | -55.8% |
Q3 2013 | $198,000 | +465.7% | 50,000 | +199.4% | 0.12% | +380.0% |
Q2 2013 | $35,000 | – | 16,700 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,642,959 | $25,186,000 | 3.76% |
MSD Partners, L.P. | 15,151,516 | $26,061,000 | 2.11% |
MSD Partners, L.P. | 7,575,758 | $13,030,000 | 1.05% |
MAGNOLIA CAPITAL ADVISORS LLC | 418,569 | $720,000 | 0.61% |
STEEL GROVE CAPITAL ADVISORS, LLC | 1,080,000 | $1,858,000 | 0.33% |
EAM Investors, LLC | 454,625 | $782,000 | 0.17% |
Allred Capital Management, LLC | 158,000 | $271,000 | 0.17% |
Boxer Capital, LLC | 1,500,000 | $2,580,000 | 0.14% |
GSA CAPITAL PARTNERS LLP | 608,037 | $1,046,000 | 0.14% |
CHIRON CAPITAL MANAGEMENT, LLC | 116,860 | $201,000 | 0.14% |